创新诊断技术:通过进步,挑战和未来前景导航监管框架
Jesus Rodriguez-Manzano1, Sumithra Subramaniam2, Chibuzor Uchea2
1Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK; ProtonDx, Translation & Innovation Hub, Imperial College London, London, UK.
The Lancet. Digital health
|November 15, 2024
概括
开发有效的传染病诊断方法至关重要,但面临着监管障碍. 英国和全球的努力旨在简化途径,以便更好地获得这些重要的健康工具.
科学领域:
- 医学诊断 医学诊断 医学诊断
- 公共卫生政策 公共卫生政策
- 监管科学 监管科学
背景情况:
- 有效的诊断工具对于管理传染病和为公共卫生战略提供信息至关重要.
- 获得可靠和负担得起的诊断测试的限制影响着全球人口的很大一部分.
- 诊断领域的创新是迫切需要的,以提高可用性和有效性,特别是对于传染病和抗菌素耐药性.
研究的目的:
- 探索与开发和实施传染病和抗菌素耐药性诊断相关的监管挑战.
- 审查英国在支持诊断创新和监管清晰度方面的举措.
- 突出旨在改善低收入和中等收入国家诊断监管框架的全球努力.
主要方法:
- 该研究审查了与诊断法规相关的现有文献和政策文件.
- 它分析了诊断领域的创新者和监管机构面临的具体挑战.
- 讨论了来自英国和国际合作的案例研究和例子.
主要成果:
- 诊断的监管途径往往比药物定义少,更复杂.
- 低收入和中等收入国家经常缺乏针对诊断的具体监管框架.
- 英国的举措重点是创造更清晰的监管途径,确保安全和有效性.
- 国际合作正在进行中,以加快对高需求地区的诊断开发.
结论:
- 协调标准和简化监管流程对于确保诊断质量,安全性和全球可访问性至关重要.
- 解决监管复杂性是加速开发和部署基本传染病诊断的关键.
- 持续的国际合作对于克服障碍和改善全球诊断的准入至关重要.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1


